Investment Thesis
Focused on early-stage life science startups in Skåne (Sweden), with a regional and international investment scope. Emphasizes companies incubated for at least six months, leveraging private and state venture capital, and providing international life science expertise.
Stage Focus
Early-stage
Preferred startup development maturity for initial funding deployment.
Sectors & Themes
Early-stage life science companies with innovative health-related solutions
Core thematic spaces, technologies, and target market segments of interest.
Check Size Range
€169,000 - €4,000,000
Standard financial allocation per investment round.
Outreach & Dossier Intelligence
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...
